Identification of LMO 2 transcriptome and interactome in diffuse large B-cell lymphoma

1Division of Hematology-Oncology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL; 2Center for Cancer Systems Biology, School of Medicine, Stanford University, Stanford, CA; 3Weill Cornell Medical College, New York, NY; 4Department of Pathology, Stanford University School of Medicine, Stanford, CA; 5Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Salamanca, Spain; 6Consultoria em Patologia, Botucatu, Brazil; and 7Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain

[1]  M. Kelliher,et al.  A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice , 2011, Oncogene.

[2]  Raja Jothi,et al.  Nuclear adaptor Ldb1 regulates a transcriptional program essential for the maintenance of hematopoietic stem cells , 2011, Nature Immunology.

[3]  Xiaoqing Lu,et al.  HGAL, a germinal center specific protein, decreases lymphoma cell motility by modulation of the RhoA signaling pathway. , 2010, Blood.

[4]  Rajendran Sanalkumar,et al.  Building multifunctionality into a complex containing master regulators of hematopoiesis , 2010, Proceedings of the National Academy of Sciences.

[5]  B. Göttgens,et al.  A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients , 2010, Oncogene.

[6]  Albert Gutierrez,et al.  LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. , 2010, Blood.

[7]  D. Curtis,et al.  The Molecular Basis of Lmo2-Induced T-Cell Acute Lymphoblastic Leukemia , 2010, Clinical Cancer Research.

[8]  C. D. de Graaf,et al.  The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal , 2010, Science.

[9]  I. Lossos,et al.  Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. , 2010, Blood.

[10]  Christian Buske,et al.  A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis , 2008, The Journal of experimental medicine.

[11]  Y. Yashiro‐Ohtani,et al.  Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas. , 2007, Blood.

[12]  L. Staudt,et al.  Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma , 2007, The Journal of experimental medicine.

[13]  I. Lossos,et al.  The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. , 2007, Blood.

[14]  V. Deleuze,et al.  TAL-1/SCL and Its Partners E47 and LMO2 Up-Regulate VE-Cadherin Expression in Endothelial Cells , 2007, Molecular and Cellular Biology.

[15]  Patrick Rodriguez,et al.  Novel binding partners of Ldb1 are required for haematopoietic development , 2006 .

[16]  Charles Lee,et al.  The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. , 2006, Blood.

[17]  J. Buerstedde,et al.  E2A Expression Stimulates Ig Hypermutation1 , 2006, The Journal of Immunology.

[18]  T. Hoang,et al.  ETO2 coordinates cellular proliferation and differentiation during erythropoiesis , 2006, The EMBO journal.

[19]  L. Pham,et al.  Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. , 2005, Blood.

[20]  P. Vyas,et al.  ETO-2 Associates with SCL in Erythroid Cells and Megakaryocytes and Provides Repressor Functions in Erythropoiesis , 2005, Molecular and Cellular Biology.

[21]  Christopher J. Wilkinson,et al.  The Polo kinase Plk4 functions in centriole duplication , 2005, Nature Cell Biology.

[22]  C. Murre.  Helix-loop-helix proteins and lymphocyte development , 2005, Nature Immunology.

[23]  V. Diehl,et al.  The early transcription factor GATA‐2 is expressed in classical Hodgkin's lymphoma , 2004, The Journal of pathology.

[24]  Ash A. Alizadeh,et al.  Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. , 2004, The New England journal of medicine.

[25]  T. Hoang,et al.  SCL Assembles a Multifactorial Complex That Determines Glycophorin A Expression , 2004, Molecular and Cellular Biology.

[26]  T. Rabbitts,et al.  The LMO2 T-Cell Oncogene Is Activated via Chromosomal Translocations or Retroviral Insertion during Gene Therapy but Has No Mandatory Role in Normal T-Cell Development , 2003, Molecular and Cellular Biology.

[27]  S. Kishikawa,et al.  Transcriptional regulation by zinc-finger proteins Sp1 and MAZ involves interactions with the same cis-elements. , 2003, International journal of molecular medicine.

[28]  Andrea Califano,et al.  Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. , 2003, The Journal of clinical investigation.

[29]  J. Kaiser.  Seeking the Cause of Induced Leukemias in X-SCID Trial , 2003, Science.

[30]  Erich A. Nigg,et al.  Centrosome aberrations: cause or consequence of cancer progression? , 2002, Nature Reviews Cancer.

[31]  T. Hoang,et al.  The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1. , 2002, Blood.

[32]  T. Rabbitts,et al.  The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target , 2002, Oncogene.

[33]  T. Hoang,et al.  SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-Tα chain expression , 2000, Nature Immunology.

[34]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[35]  T. Rabbitts,et al.  The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  C. Murre,et al.  E2A activity is induced during B‐cell activation to promote immunoglobulin class switch recombination , 1999, The EMBO journal.

[37]  O. Yoshie,et al.  TAL1 and LIM-Only Proteins Synergistically Induce Retinaldehyde Dehydrogenase 2 Expression in T-Cell Acute Lymphoblastic Leukemia by Acting as Cofactors for GATA3 , 1998, Molecular and Cellular Biology.

[38]  T. Rabbitts,et al.  The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Rabbitts,et al.  The LIM‐only protein Lmo2 is a bridging molecule assembling an erythroid, DNA‐binding complex which includes the TAL1, E47, GATA‐1 and Ldb1/NLI proteins , 1997, The EMBO journal.

[40]  Y. Ono,et al.  Transcriptional Activity of TAL1 in T Cell Acute Lymphoblastic Leukemia (T-ALL) Requires RBTN1 or −2 and Induces TALLA1, a Highly Specific Tumor Marker of T-ALL* , 1997, The Journal of Biological Chemistry.

[41]  A. Goldfarb,et al.  Involvement of the E2A basic helix-loop-helix protein in immunoglobulin heavy chain class switching. , 1996, Molecular immunology.

[42]  M. Cleary,et al.  Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells , 1996, Molecular and cellular biology.

[43]  T. Rabbitts,et al.  The oncogenic LIM protein Rbtn2 causes thymic developmental aberrations that precede malignancy in transgenic mice. , 1995, Oncogene.

[44]  T. Rabbitts,et al.  Functional diversity of LIM proteins: amino-terminal activation domains in the oncogenic proteins RBTN1 and RBTN2. , 1995, Oncogene.

[45]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[46]  A. Nordheim,et al.  Activation of ternary complex factor Elk‐1 by MAP kinases. , 1993, The EMBO journal.

[47]  R. Baer.  TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. , 1993, Seminars in cancer biology.

[48]  T. Rabbitts,et al.  T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. , 1992, Oncogene.

[49]  M. Perutz,et al.  The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[50]  H. Clevers,et al.  Identification and cloning of TCF‐1, a T lymphocyte‐specific transcription factor containing a sequence‐specific HMG box. , 1991, The EMBO journal.

[51]  T. Rabbitts,et al.  The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif. , 1990, Oncogene.